Production Cost Report
pyrantel-pamoate-e11a
cefalotin-e11a,bronopol-e11a,rifampicin-e11a
Pyrantel Pamoate
Pyrantel Pamoate
Pyrantel Embonate
Pyrantel Pamoate (a.k.a. Pyrantel Embonate) is a medication belonging to the class of drugs known as anthelmintics, with activity against intestinal nematodes, such as pinworm, hookworms and roundworms. It is used mainly in the oral treatment of domesticated animals infected with these parasites. Pyrantel Pamoate acts as a depolarizing neuromuscular-blocking agent causing longstanding nicotinic receptor activation, resulting in spastic paralysis of susceptible nematodes.

Pyrantel Pamoate Production Cost Reports - Q2 2019

Capital Investment & Operating Cost of Pyrantel Pamoate Plants

Pyrantel Pamoate (a.k.a. Pyrantel Embonate) is a medication belonging to the class of drugs known as anthelmintics, with activity against intestinal nematodes, such as pinworm, hookworms and roundworms. It is used mainly in the oral treatment of domesticated animals infected with these parasites. Pyrantel Pamoate acts as a depolarizing neuromuscular-blocking agent causing longstanding nicotinic receptor activation, resulting in spastic paralysis of susceptible nematodes.

Intratec offers professional, easy-to-understand reports examining Pyrantel Pamoate production. Each study describes an industrial plant, including main process units and site infrastructure, and presents an independent analysis of capital and operating costs. All reports are based on the most recent economic data available (Q2 2019).

You can find below reports focused on Pyrantel Pamoate production processes currently offered by Intratec. If none of the off-the-shelf reports listed below fits your needs, you can request a bespoke report tailored to your needs, for as low as USD 2,900!

Pyrantel Pamoate Production Process | Pyrantel Pamoate E11A

This report presents the economics of Pyrantel Pamoate production from 2-thiophene aldehyde in the USA. 3-Methylamine propylamine is first sent to a cyclization step before it is reacted with 2-thiophene aldehyde. Ethanol and citric acid are added to the reaction product, followed by the addition of a pamoic acid solution for recrystallization, obtaining pyrantel pamoate.

Details: 0.01 kta United States-based plant   |   Q2 2019   |   106 pages   From $1,999

The cost analyses presented in the report Pyrantel Pamoate E11A target a 0.01 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Could Not Find the Production Cost Report you Need?

If none of the Pyrantel Pamoate reports listed above fits your needs, you can request a bespoke report examining the process you are interested in! You will have a report tailored to your needs, in which you defined production process, industrial plant capacity and location!

Details: Customer-defined Plant Location & Capacity  |   Q2 2019 From $2,900

Customers Who Bought This Report Also Bought

Bronopol Production Process - Cost Analysis | Bronopol E11A

This report presents the economics of a typical Bronopol production process from sodium hydroxide, calcium chloride, nitromethane, and liquid bromine in the USA.

Details: 100 kta United States-based plant   |   Q2 2019   |   106 pages From $1,999

The cost analyses presented in the report Bronopol E11A target a 100 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Cefalotin Production Process - Cost Analysis | Cefalotin E11A

This report presents the economics of a typical Cefalotin production process in the USA. In this process, 2-TAC is reacted in 7-ACA suspension, with sodium acetate added to the reaction mixture for crystallization.

Details: 0 kta United States-based plant   |   Q2 2019   |   106 pages From $1,999

The cost analyses presented in the report Cefalotin E11A target a 0 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Rifampicin Production via Fermentation - Cost Analysis | Rifampicin E11A

This report presents the economics of Rifampicin production from mixed carbon sources (peanut meal, soybean flour, glucose, and starch) in the USA, via a typical fermentation process of Nocardi mediterranei. The fermentation produces rifamycin B, which is further processed to rifamycin-O, then to rifamycin-S, then to rifamycin SV, and finally to Rifampicin.

Details: 0.02 kta United States-based plant   |   Q2 2019   |   106 pages From $1,999

The cost analyses presented in the report Rifampicin E11A target a 0.02 kta (kilometric tons per annun) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Use our Reports as

Feasibility Studies

Techno-economic Evaluations

Investment Analyses

Multi-regional Cost Analyses

Trusted By

BASF
Monsanto
Linde